Skip to content

Total Assets at other companies

Incyte logo
IncyteINCY
$7.34B+27.7%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
$253.2M+326%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$99.89M-27.9%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$102.12M+32.3%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$1.29B+81.1%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$1.67B+81.7%

Other financials

Income statement

See full
Revenue$2.0M+37.2%
Gross profit$1.6M+68.7%
Operating income-$22.2M-22.7%
Net income-$19.8M-31.4%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$28.7M-5.6%
Total debt$2.0M-20.1%
Total equity$143.6M-0.3%

Cash flow

See full
Operating cash flow-$18.1M-39.0%
CapEx$13.0K-69.8%
Free cash flow-$18.2M-38.6%

Valuation

See full
Market cap$685.75M+337%
Enterprise value$659.07M+410%
P/S82×+73.1×

Profitability

See full
Gross margin76.3%-9.7pp
Operating margin-961.9%+259pp
Net margin-832.6%+132pp
FCF margin-624.9%

Returns & leverage

See full
Return on equity-48.4%-15.4pp
Debt / equity0.0×
Current ratio-1.0×

Where this comes from

Reported directly by Aclaris Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aclaris Therapeutics's total assets?
Aclaris Therapeutics (ACRS) reported total assets of $198.72M in Q1 2026.
How has Aclaris Therapeutics's total assets changed year-over-year?
Aclaris Therapeutics's total assets increased by 0.3% year-over-year, from $198.09M to $198.72M.
What is the long-term trend for Aclaris Therapeutics's total assets?
Over 5 years (2020 to 2025), Aclaris Therapeutics's total assets has grown at a 17.8% compound annual growth rate (CAGR), from $70.78M to $160.46M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.